Bibliography
- Drees BE, Mill GB, Rommel C, Prestwich GD. Therapeutic Potential of Phosphoinosite-3 kinase inhibitors et al. Expert Opin Ther Patent 2004;14(5):703-32
- Bowles DW, Jimeno A. New phosphatidylinositol 3-kinase inhibitors for cancer. Expert Opin Investig Drugs 2011;20(4):507-18
- Chantry D, Vojtek A, Kashishian A, p110delta, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes. J Biol Chem 1997;272(31):19236-41
- Vanhaesebroeck B, Welham MJ, Kotani K, P110delta, a novel phosphoinositide 3-kinase in leukocytes. Proc Natl Acad Sci USA 1997;94(9):4330-5
- Ikeda H, Hideshima T, Fulciniti M, PI3K/p110delta is a novel therapeutic target in multiple myeloma. Blood 2010;116(9):1460-8
- ICOS Corp. Inhibitors of human phosphatidylinositol 3-kinase delta. US6518277; 2003
- Sadhu C, Dick K, Tino WT, Staunton DE. Selective role of PI3K delta in neutrophil inflammatory responses. Biochem Biophys Res Commun 2003;308(4):764-9
- Lannutti BJ, Meadows SA, Herman SE, CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. Blood 2011;117(2):591-4
- Norman P. Selective PI3Kdelta inhibitors, a review of the patent literature. Exp Opin Ther Pat 2011; In press
- F. Hoffmann-La Roche AG. Quinazoline derivatives as PI3 kinase inhibitors. WO2008152387; 2008
- Amgen, Inc. delta3- Substituted Quinoline or Quinoxaline derivatives and their use as Phosphatidylinositol 3-Kinase (PI3K) inhibitors. WO2008118455; 2008
- Amgen, Inc. Heterocyclic compounds and their uses as inhibitors of PI3K activity. WO2010151737; 2010
- Amgen, Inc. Derivatives of Quinoline or Benzopyrazine and their uses for the Treatment of (Inter Alia) Inflammatory Diseases, Autoimmune Diseases or Various Kinds of Cancer. WO2008118454; 2008
- AMG 319 Lymphoid Malignancy FIH 2011. Available from: http://clinicaltrials.gov/ct2/show/NCT01300026
- Amgen, Inc. Heterocyclic compounds and their uses. WO2010151791; 2010